Form 4 for DERM Journey Medical Corp

Accepted 2025-05-05 00:00:00 ET · period of report 2025-05-02 · accession 0001104659-25-044612 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2025-05-05	2025-05-02	DERM	Maraoui Claude	Pres, CEO, Dir	S - Sale	$6.84	-4,834	2.35M	-0.2%	-$33.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, $0.0001 par value	2025-05-02	S	D	4,834	$6.84	2,348,313	D	—	—	(F1) In connection with the vesting of restricted stock units which vested as of various dates, a total of 4,834 of the underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units. (F2) Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on May 2, 2025, was $6.73 to $7.05. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price. (F3) Includes restricted stock units, which vest over various time periods.